Technology: SenesTech believes its technology is the first of its kind inthe world. We are conducting cutting-edge research in mammalian female senescence and developing animal research models, advancing efforts in wildlife population management, and developing companion animal chemical spay technology. The technology is based on the development of species-specific protocols to chemically accelerate the natural depletion of the non-regenerating pool of primordial and primary follicles in the mammalian ovary, resulting in ovarian failure and sterility. The protocol has been refined and optimized to achieve follicle depletion without causing systemic toxicity or adverse side effects and is environmentally neutral, so it will not affect the food chain.
Company Background: SenesTech was founded in 2002 in Flagstaff, Arizona and is based on technology licensed from the University of Arizona. It has recently entered into a strategic alliance with the government of Australia to service the needs of Australia, New Zealand, and Southeast Asia in rodent population management. Domestic and International patents are pending.
Management: Everett P. Hale is SenesTech’s Chief Executive Officer. Mr. Hale has extensive experience in management, operations and taking start-up companies to the IPO stage. Three scientists have been involved in the research that forms the basis of SenesTech’s platform technology. Loretta P. Mayer, Ph.D. is the Chief Scientific Officer and serves as Chairman of the Board. Cheryl A. Dyer, Ph.D. is the lead scientist for development of commercial delivery of the technology and serves as President. Timothy L. Vail, Ph.D. is the Vice President of Manufacturing and Regulation. Roger Bollard, CPA is the Chief Financial Officer.
Market: Initial market analyses indicate a primary market in rodent management within agriculture, with a secondary market in companion animal chemical spay. SenesTech’s rodent fertility control product ContraPest™ will replace the use of poisons in a world market that can suffer up to 33% crop losses due to rodent infestations. Annual sales are projected to supplant current poison products within three years with annual revenue in excess of $1 billion. A humane method for population management of wild animals such as deer, coyotes, foxes, raccoons, horses, buffalo, elk as well as feral dogs and cats represent potential follow-on market segments. At an international meeting of scientists in Washington DC in November 2006 ChemSpay™ was determined to be the only irreversible product in development that can adequately address the dog and cat overpopulation problems.
Products and Services: ContraPest™, which will be delivered via oral baiting, will be registered first in Australia and marketed to the Southeast Asian rice producing countries to address the immediate need of increased rice production to help alleviate world-wide famine. The technology will then be expanded to other species and subsequently to address the overpopulation of feral dogs and cats, as well as, companion animals worldwide as ChemSpay™.
